Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Human vaccinia immune globulin

Known as: vaccinia immune globulin, vaccinia immunoglobulin 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Enhanced Efficacy of Cidofovir Combined with Vaccinia Immune Globulin in Treating Progressive Cutaneous Vaccinia Virus Infections in Immunosuppressed Hairless Mice
ABSTRACT The treatment of progressive vaccinia in individuals has involved antiviral drugs, such as cidofovir (CDV… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2010
2010
Postexposure Prevention of Progressive Vaccinia in SCID Mice Treated with Vaccinia Immune Globulin
ABSTRACT A recently reported case of progressive vaccinia (PV) in an immunocompromised patient has refocused attention on this… Expand
Is this relevant?
2009
2009
Effective post-exposure protection against lethal orthopoxviruses infection by vaccinia immune globulin involves induction of adaptive immune response.
The therapeutic potential of human vaccinia immunoglobulin (VIG) in orthopoxvirus infection was examined using two mouse models… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 5
Is this relevant?
Review
2006
Review
2006
Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy.
  • Riccardo Wittek
  • International journal of infectious diseases…
  • 2006
    • Corpus ID: 24170796
In 1980 the World Health Organization declared that smallpox was eradicated from the world, and routine smallpox vaccination was… Expand
  • table 2
  • table 3
  • table 4
  • table 5
  • table 6
Is this relevant?
2005
2005
Identification and preliminary characterization of vaccinia virus (Dryvax) antigens recognized by vaccinia immune globulin.
Using vaccinia immune globulin (VIG), a high-titer antibody preparation from immunized subjects, we demonstrate that the humoral… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin.
In the event of smallpox bioterrorism, widespread vaccination may be required. Vaccinia immune globulin (VIG) has been used to… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2004
2004
Safety and pharmacokinetic evaluation of intravenous vaccinia immune globulin in healthy volunteers.
BACKGROUND Vaccinia immune globulin (VIG) administered via the intramuscular route has historically been used for the treatment… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Smallpox vaccination and adverse reactions. Guidance for clinicians.
The guidance in this report is for evaluation and treatment of patients with complications from smallpox vaccination in the… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
2003
2003
Development of a novel vaccinia-neutralization assay based on reporter-gene expression.
In anticipation of large-scale smallpox vaccination, clinical trials of new vaccine candidates with improved safety profiles, and… Expand
Is this relevant?
Review
2003
Review
2003
Pathogenesis and potential antiviral therapy of complications of smallpox vaccination.
  • Mike Bray
  • Antiviral research
  • 2003
    • Corpus ID: 24297655
Vaccination against smallpox may result in a variety of complications, ranging in severity from benign to lethal. Universal… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE